Magrath George 4
4 · Opus Genetics, Inc. · Filed Mar 26, 2025
Insider Transaction Report
Form 4
Magrath George
DirectorChief Executive Officer
Transactions
- Award
Warrants (right to buy)
2025-03-24+392,157→ 392,157 totalExercise: $1.15Exp: 2030-03-24→ Common Stock (392,157 underlying) - Award
Common Stock
2025-03-24+392,157→ 1,322,004 total
Footnotes (2)
- [F1]Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275.
- [F2]These warrants are immediately exercisable and may be called by the Issuer at any time starting with 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's common stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day.